oa SA Pharmaceutical Journal - Medicine registration numbers : industry in-site



The thalidomide tragedy in the early 1960s prompted authorities to introduce an evaluation system globally whereby the safety, efficacy and quality of any new medicine had to be assessed and approved before the medicine, including complementary medicines, was marketed. Prior to this, there was no formal system of medicine registration and any new preparation could be introduced onto the market without the manufacturer having carried out preclinical and clinical testing, and without having had the manufacturing materials and procedures regulated and approved.


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error